Fresenius | FRE - Marktkapitalisierung

Aktienkurs
40.25
Täglich Wechseln
-0.46 -1.13%
Monatlich
-9.57%
Jährlich
1.00%
Q2 Prognose
39.19




Marktkapitalisierung Veränderung Datum
Akzo Nobel EUR 9.05B 629.79M 2026-04
Alcon AG USD 31.08B 1.97B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
BASF EUR 39.65B 1.82B 2025-12
Bayer EUR 36.36B 9.13B 2025-12
Beiersdorf EUR 22.73B 3.43B 2025-12
DaVita Healthcare Partners USD 7.79B 1.64B 2025-12
Demant DKK 46.01B 10.48B 2025-12
E.ON EUR 42.59B 771.27M 2025-12
Essilor EUR 92.03B 33.02B 2026-04
Fresenius EUR 27.59B 889.91M 2025-12
Fresenius Medical Care EUR 11.96B 1.14B 2025-12
Givaudan CHF 29.05B 6.42B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
GN Store Nord DKK 16.11B 98.09M 2025-12
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 53.3B 5.72B 2025-12
Novartis USD 292.21B 26.55B 2025-12
Philips EUR 22.38B 192.58M 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
RWE EUR 33.67B 6.24B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
Smith & Nephew USD 3.77B 9.55B 2026-04